Unknown

Dataset Information

0

Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2.


ABSTRACT: Niclosamide, an oral anthelmintic drug, could inhibit SARS-CoV-2 virus replication through autophagy induction, but high cytotoxicity and poor oral bioavailability limited its application. Twenty-three niclosamide analogs were designed and synthesized, of which compound 21 was found to exhibit the best anti-SARS-CoV-2 efficacy (EC50 = 1.00 μM for 24 h), lower cytotoxicity (CC50 = 4.73 μM for 48 h), better pharmacokinetic, and it was also well tolerated in the sub-acute toxicity study in mice. To further improve the pharmacokinetics of 21, three prodrugs have been synthesized. The pharmacokinetics of 24 indicates its potential for further research (AUClast was 3-fold of compound 21). Western blot assay indicated that compound 21 could down-regulate SKP2 expression and increase BECN1 levels in Vero-E6 cells, indicating the antiviral mechanism of 21 was related to modulating the autophagy processes in host cells.

SUBMITTER: Li R 

PROVIDER: S-EPMC10073089 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2.

Li Rui R   Zhang Zherui Z   Huang Shuhong S   Peng Ke K   Jiang Hualiang H   Shen Jingshan J   Zhang Bo B   Jiang Xiangrui X  

European journal of medicinal chemistry 20230405


Niclosamide, an oral anthelmintic drug, could inhibit SARS-CoV-2 virus replication through autophagy induction, but high cytotoxicity and poor oral bioavailability limited its application. Twenty-three niclosamide analogs were designed and synthesized, of which compound 21 was found to exhibit the best anti-SARS-CoV-2 efficacy (EC<sub>50</sub> = 1.00 μM for 24 h), lower cytotoxicity (CC<sub>50</sub> = 4.73 μM for 48 h), better pharmacokinetic, and it was also well tolerated in the sub-acute toxi  ...[more]

Similar Datasets

| S-EPMC8933873 | biostudies-literature
| S-EPMC9270844 | biostudies-literature
| S-EPMC8383483 | biostudies-literature
| S-EPMC10377517 | biostudies-literature
| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
| S-SCDT-10_1038-S44319-024-00189-4 | biostudies-other
| S-EPMC6931042 | biostudies-literature
| S-EPMC10222209 | biostudies-literature
| S-EPMC10976223 | biostudies-literature
| S-EPMC8305101 | biostudies-literature